Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Receivables - Net (2020 - 2025)

Historic Receivables - Net for Oncology Institute (TOI) over the last 6 years, with Q3 2025 value amounting to $59.6 million.

  • Oncology Institute's Receivables - Net rose 942.53% to $59.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.6 million, marking a year-over-year increase of 942.53%. This contributed to the annual value of $48.3 million for FY2024, which is 1410.53% up from last year.
  • According to the latest figures from Q3 2025, Oncology Institute's Receivables - Net is $59.6 million, which was up 942.53% from $55.7 million recorded in Q2 2025.
  • In the past 5 years, Oncology Institute's Receivables - Net ranged from a high of $59.6 million in Q3 2025 and a low of $20.0 million during Q4 2021
  • For the 5-year period, Oncology Institute's Receivables - Net averaged around $44.5 million, with its median value being $47.4 million (2023).
  • As far as peak fluctuations go, Oncology Institute's Receivables - Net skyrocketed by 9901.03% in 2022, and later crashed by 1606.54% in 2025.
  • Quarter analysis of 5 years shows Oncology Institute's Receivables - Net stood at $20.0 million in 2021, then soared by 99.01% to $39.8 million in 2022, then grew by 6.39% to $42.4 million in 2023, then increased by 14.11% to $48.3 million in 2024, then grew by 23.39% to $59.6 million in 2025.
  • Its Receivables - Net stands at $59.6 million for Q3 2025, versus $55.7 million for Q2 2025 and $49.3 million for Q1 2025.